Longer lifespan in male mice treated with a weakly estrogenic agonist, an antioxidant, an α-glucosidase inhibitor or a Nrf2-inducer

Randy Strong, Richard A. Miller, Adam Antebi, Clinton M. Astle, Molly Bogue, Martin S. Denzel, Elizabeth Fernandez, Kevin Flurkey, Karyn L. Hamilton, Dudley W. Lamming, Martin A. Javors, João Pedro de Magalhães, Paul Anthony Martinez, Joe M. McCord, Benjamin F. Miller, Michael Müller, James F. Nelson, Juliet Ndukum, G. Ed Rainger, Arlan RichardsonDavid M. Sabatini, Adam B. Salmon, James W. Simpkins, Wilma T. Steegenga, Nancy L. Nadon, David E. Harrison

Producción científica: Article › revisión exhaustiva

266 Citas (Scopus)

Huella

Profundice en los temas de investigación de 'Longer lifespan in male mice treated with a weakly estrogenic agonist, an antioxidant, an α-glucosidase inhibitor or a Nrf2-inducer'. En conjunto forman una huella única.

Medicine and Dentistry